Voices
Mike Thompson: Precision Hematology – Next Generation Clinical Trial Design
Mike Thompson/LinkedIn

Mike Thompson: Precision Hematology – Next Generation Clinical Trial Design

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:

“Precision hematology: Next generation clinical trial design – EHA2026 Clinical Trial by Simon Richardson”

Mike Thompson

Other articles featuring Mike Thompson and on OncoDaily.

cancer EHA EHA 2026 EHA2026 EHA26 Mike Thompson OncoDaily Oncology Simon Richardson